Category:Multiple sclerosis

• Multiple sclerosis

A

• Acute disseminated encephalomyelitis

B

• Biomarkers of multiple sclerosis

C

• Calcium 2-aminoethylphosphate
• Chronic cerebrospinal venous insufficiency controversy
• Clinically isolated syndrome

D

• Diroximel fumarate
• Dirucotide

E

• Expanded Disability Status Scale

F

• Fingolimod

H

• Stephen L. Hauser

I

• Inflammatory demyelinating diseases of the central nervous system

L

• Lesional demyelinations of the central nervous system
• Lhermitte's sign
• Statue of Charles Linn

M

• Malignant multiple sclerosis
• Management of multiple sclerosis
• Marburg acute multiple sclerosis
• Anne-Marie McDaid
• McDonald criteria
• W. Ian McDonald
• MIS416
• MOG antibody disease
• Monomethyl fumarate
• MS Readathon
• Diagnosis of multiple sclerosis
• Multiple Sclerosis Discovery Forum
• Multiple sclerosis drug pipeline
• Multiple sclerosis functional composite

P

• Pathology of multiple sclerosis
• Pathophysiology of multiple sclerosis
• Patient Reported Outcome Indices for Multiple Sclerosis
• Peginterferon beta-1a
• Ponesimod
• Poser criteria

R

• Radiologically isolated syndrome
• Research in multiple sclerosis

S

• Schumacher criteria
• Signs and symptoms of multiple sclerosis
• Siponimod
• Speedbumps: Flooring It Through Hollywood
• Sphingosine-1-phosphate receptor modulator
• Swank diet

T

• Temelimab
• Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
• Stanisław Tołpa
• Transverse myelitis
• Truncal ataxia
• Tumefactive multiple sclerosis

U

• Uhthoff's phenomenon
• Unidimensional Fatigue Impact Scale

V

• Rhonda Voskuhl

W

• Howard L. Weiner
• Hartmut Wekerle